Literature DB >> 19779737

Modeling familial British and Danish dementia.

Holly J Garringer1, Jill Murrell, Luciano D'Adamio, Bernardino Ghetti, Ruben Vidal.   

Abstract

Familial British dementia (FBD) and familial Danish dementia (FDD) are two autosomal dominant neurodegenerative diseases caused by mutations in the BRI ( 2 ) gene. FBD and FDD are characterized by widespread cerebral amyloid angiopathy (CAA), parenchymal amyloid deposition, and neurofibrillary tangles. Transgenic mice expressing wild-type and mutant forms of the BRI(2) protein, Bri ( 2 ) knock-in mutant mice, and Bri ( 2 ) gene knock-out mice have been developed. Transgenic mice expressing a human FDD-mutated form of the BRI ( 2 ) gene have partially reproduced the neuropathological lesions observed in FDD. These mice develop extensive CAA, parenchymal amyloid deposition, and neuroinflammation in the central nervous system. These animal models allow the study of the molecular mechanism(s) underlying the neuronal dysfunction in these diseases and allow the development of potential therapeutic approaches for these and related neurodegenerative conditions. In this review, a comprehensive account of the advances in the development of animal models for FBD and FDD and of their relevance to the study of Alzheimer disease is presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779737     DOI: 10.1007/s00429-009-0221-9

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  23 in total

1.  Tuning of Glutamate, But Not GABA, Release by an Intrasynaptic Vesicle APP Domain Whose Function Can Be Modulated by β- or α-Secretase Cleavage.

Authors:  Wen Yao; Marc D Tambini; Xinran Liu; Luciano D'Adamio
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

2.  Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis.

Authors:  Robert Tamayev; Luca Giliberto; Wei Li; Cristina d'Abramo; Ottavio Arancio; Ruben Vidal; Luciano D'Adamio
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

3.  BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.

Authors:  M Del Campo; C R Oliveira; W Scheper; R Zwart; C Korth; A Müller-Schiffmann; G Kostallas; H Biverstal; J Presto; J Johansson; J J Hoozemans; C F Pereira; C E Teunissen
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

4.  Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration.

Authors:  Dolores Del Prete; Richard C Rice; Anjali M Rajadhyaksha; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

5.  Amyloid and intracellular accumulation of BRI2.

Authors:  Holly J Garringer; Neeraja Sammeta; Adrian Oblak; Bernardino Ghetti; Ruben Vidal
Journal:  Neurobiol Aging       Date:  2016-12-29       Impact factor: 4.673

6.  Increased AβPP processing in familial Danish dementia patients.

Authors:  Shuji Matsuda; Robert Tamayev; Luciano D'Adamio
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant.

Authors:  Robert Tamayev; Shuji Matsuda; Luca Giliberto; Ottavio Arancio; Luciano D'Adamio
Journal:  EMBO J       Date:  2011-05-17       Impact factor: 11.598

8.  Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivo.

Authors:  Luca Giliberto; Cristina d'Abramo; Christopher Michael Acker; Peter Davies; Luciano D'Adamio
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice.

Authors:  Holly J Garringer; Jill Murrell; Neeraja Sammeta; Anita Gnezda; Bernardino Ghetti; Ruben Vidal
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Proteomic characterization of a mouse model of familial Danish dementia.

Authors:  Monica Vitale; Giovanni Renzone; Shuji Matsuda; Andrea Scaloni; Luciano D'Adamio; Nicola Zambrano
Journal:  J Biomed Biotechnol       Date:  2012-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.